Loading clinical trials...
Loading clinical trials...
This is an adaptive prospective, multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of WAL0921 in subjects with g...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Walden Biosciences
NCT04916132 · Chronic Kidney Diseases, Albuminuria, and more
NCT05505500 · Fluid Overload, Glomerulosclerosis, Focal Segmental, and more
NCT03949972 · Glomerulosclerosis, Focal Segmental, Minimal Change Disease, and more
NCT05650619 · Focal Segmental Glomerulosclerosis, Minimal Change Disease, and more
NCT06846034 · Diabetes, Diabetic Kidney Disease, and more
Colorado Kidney and Vascular Care
Denver, Colorado
D & H Tamarac Research Center
Tamarac, Florida
Westmead Hospital
Westmead, New South Wales
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions